Lana Morrow, ph.d.
“Evoked Potentials and Multiple Channel recording.” S. L. Frkovich - Morrow. In: S. Nielsen, O. Ollson Eds., Structure and Perception of Electroacustic Sound and Music, Excerpta Medica, Amsterdam 1988
“A short Latency Cortical Component of the Foveal Ovenset VEP is Revealed by Hemifield Stimulation.” S. L. Frkovich - Morrow, Nicoll, J., and Bodis-Wollner, Electroencephalogr Clinical Neurophysiology 1992 May-Jun;84(3):201-8.
“The Topography of the N70 Component of the VEP in Humans. In : Maurer K. Ed. Topographic Brain Mapping of EEG and Evoked Potentials,” Springer Verlag, Heidelberg, Bodis-Wollner, I., S. L. Frkovich - Morrow, and Mylin, L. EEG Journal 1988
“L-Dopa Carbidopa and Parkinson's Disease - an Evoked Potentials Study” Sollazzo, D., S. L. Frkovich - Morrow, and Scarinci, A., First Congress of The Italian Society of Neuroscience 1984
“Influence of L-Dopa Carbidopa on the Visual Evoked Potentials In patients with Idiopatic and non-Idiopatic Parkinson's Disease - an Evoked Potentials Study.” S. L. Frkovich - Morrow. EEG Journal 1984
Francesco Boccalatte, ph.d
“The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells.” Bryan King, Francesco Boccalatte, Kelly Moran-Crusio, et al. Nature Immunology, 17,1312–1321(2016) doi:10.1038/ni.3559
“Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.” Erika Zonari, Giacomo Desantis, Francesco E. Boccalatte, Luigi Naldini. Stem Cell Reports, Volume 8, Issue 4, p977–990, 11 April 2017
“miR-126 orcherstrates an oncogenic program in B-cell precursor acute lymphoblastic leukemia.” Nucera S*, Giustacchini A*, Boccalatte F, et al. Cancer Cell, 2016 Jun 13;29(6):905-21. doi: 10.1016/j.ccell.2016.05.007.
“MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.” Gentner B, Pochert N, Rouhi A, Boccalatte F, et al. Experimental Hematology, 2015 Oct;43(10):858-868.e7. doi: 10.1016/j.exphem.2015.05.018.
“The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1.” Voena C, Di Giacomo F, Panizza E, D'Amico L, Boccalatte F, et al. Oncogenesis, 2013 Apr 8; 2:e43. doi: 10.1038/oncsis.2013.7. Cancer Res. 2007 May 1;67(9):4278-86.
“Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes.” R Piva, E Pellegrino, M Mattioli, L Agnelli, L Lombardi, F Boccalatte, et al. The Journal of Clinical Investigation, 116 (12), 3171-3182 2006
“Attenuation of miR-126 activity expands HSC in vivo without exhaustion.” ER Lechman, B Gentner, P van Galen, A Giustacchini, M Saini, F Boccalatte, et al. Cell Stem Cell, 11 (6), 799-811 2012
“The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.” C Voena, C Conte, C Ambrogio, EB Erba, F Boccalatte, et al. Cancer Research, 67 (9), 4278-4286 2007
“The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis.” F Boccalatte, et al. Blood, 113 (12), 2776-2790 2009
“Assessment of tocilizumab in the treatment of cancer cachexia.” A Berti, F Boccalatte, et al. Journal of Clinical Oncology, 31 (23), 2970-2970 2013
Jean Christophe Corvol, m.d., ph.d.
“Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.” Liu G, Locascio JJ, Corvol JC, et al. Lancet Neurology, 2017 Aug;16(8):620-629. doi: 10.1016/S1474-4422(17)30122-9. Epub 2017 Jun 16.
“Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.” Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, et al. Lancet Neurology, 2012 Jul;11(7):589-96.
“PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.” Francois Mouton-Liger, Maxime Jacoupy, Jean-Christophe Corvol, and Olga Corti. Frontiers in Molecular Neuroscience, 01 May 2017 | https://doi.org/10.3389/fnmol.2017.00120
“Migraine in cervical artery dissection and ischemic stroke patients.” Metso TM, Tatlisumak T, Debette S, Dallongeville J, Engelter ST, Lyrer PA, Thijs V, Bersano A, Abboud S, Leys D, Grond-Ginsbach C, Kloss M, Touzé E, Pezzini A, Metso AJ; CADISP group. Neurology, 2012 Apr 17;78(16):1221-8.
“Large-scale replication and heterogeneity in Parkinson disease genetic loci.” Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, GEO-PD Consortium, et al. Neurology, 2012 Aug 14;79(7):659-67.
“A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.” Elodie Hainque, Samantha Caillet, Jean-Christophe Corvol, et al. Orphanet Journal of Rare Diseases, 201712:160 https://doi.org/10.1186/s13023-017-0713-2
“Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.” Ganqiang Liu, Brendon Boot, Joseph J. Locascio, Jacobus J. van Hilten, Florence Cormier‐Dequaire, Jean‐Christophe Corvol, et al. Annals of Neurology, 2016 Nov;80(5):674-685. doi: 10.1002/ana.24781.
“Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial.” Rosso C, Corvol JC, et al. Stroke, 2012 Sep;43(9):2343-9.
“Inflammatory profile in LRRK2-associated prodromal and clinical PD.” Kathrin Brockmann, Anja Apel, Claudia Schulte, Jean-Christophe Corvol, et al. Journal of Neuroinflammation, 201613:122 https://doi.org/10.1186/s12974-016-0588-5
“Gender and cervical artery dissection.” Metso AJ, Metso TM, Debette S, Dallongeville J, Lyrer PA, CADISP Group, et al. European Journal of Neurology. 2012 Apr;19(4):594-602.